Parkway Life REIT Could Post Near 20% DPU Gain This Year -- Market Talk

Dow Jones

02/03

0316 GMT - Parkway Life REIT is likely to report a near 20% gain in distribution per unit in 2026, thanks to a projected rental step-up for Singapore hospitals, say DBS Group Research analysts in commentary. The Singapore hospital segment accounted for most of the real-estate investment trust's higher portfolio valuation, they say. The analysts expect potential further upside if a key Singapore hospital delivers stronger-than-expected revenue after its asset enhancements, which are almost fully completed. DPU growth could also be driven by acquisitions and other asset enhancements, as the trust has ample debt headroom, the analysts say. DBS continues to like Parkway Life for its high-quality earnings visibility and maintains a buy rating and S$4.75 target price. Units rise 0.5% to S$4.09. (megan.cheah@wsj.com)

(END) Dow Jones Newswires

February 02, 2026 22:16 ET (03:16 GMT)

应版权方要求，你需要登录查看该内容

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/2608848715"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2608848715\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2608848715?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-02-03 11:16","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2608848715","market":"sg","top_or_hot":-1,"title":"Parkway Life REIT Could Post Near 20% DPU Gain This Year -- Market Talk","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n     0316 GMT - <a href=\"https://laohu8.com/S/C2PU.SI\">Parkway Life REIT</a> is likely to report a near 20% gain in distribution per unit in 2026, thanks to a projected rental step-up for Singapore hospitals, say DBS Group Research analysts in commentary. The Singapore hospital segment accounted for most of the real-estate investment trust's higher portfolio valuation, they say. The analysts expect potential further upside if a key Singapore hospital delivers stronger-than-expected revenue after its asset enhancements, which are almost fully completed. DPU growth could also be driven by acquisitions and other asset enhancements, as the trust has ample debt headroom, the analysts say. DBS continues to like Parkway Life for its high-quality earnings visibility and maintains a buy rating and S$4.75 target price. Units rise 0.5% to S$4.09. (megan.cheah@wsj.com) \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  February 02, 2026 22:16 ET (03:16 GMT)\n</p>\n<p>\n  Copyright (c) 2026 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Parkway Life REIT Could Post Near 20% DPU Gain This Year -- Market Talk</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nParkway Life REIT Could Post Near 20% DPU Gain This Year -- Market Talk\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2026-02-03 11:16</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n     0316 GMT - <a href=\"https://laohu8.com/S/C2PU.SI\">Parkway Life REIT</a> is likely to report a near 20% gain in distribution per unit in 2026, thanks to a projected rental step-up for Singapore hospitals, say DBS Group Research analysts in commentary. The Singapore hospital segment accounted for most of the real-estate investment trust's higher portfolio valuation, they say. The analysts expect potential further upside if a key Singapore hospital delivers stronger-than-expected revenue after its asset enhancements, which are almost fully completed. DPU growth could also be driven by acquisitions and other asset enhancements, as the trust has ample debt headroom, the analysts say. DBS continues to like Parkway Life for its high-quality earnings visibility and maintains a buy rating and S$4.75 target price. Units rise 0.5% to S$4.09. (megan.cheah@wsj.com) \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  February 02, 2026 22:16 ET (03:16 GMT)\n</p>\n<p>\n  Copyright (c) 2026 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU2237957811.SGD","symbol_name":"NIKKO AM GLOBAL EQUITY \"F\" (SGD) ACC","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2608848715","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2608848715","pubTimestamp":1770088560,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"0316 GMT - Parkway Life REIT is likely to report a near 20% gain in distribution per unit in 2026, thanks to a projected rental step-up for Singapore hospitals, say DBS Group Research analysts in commentary. The Singapore hospital segment accounted for most of the real-estate investment trust's higher portfolio valuation, they say. The analysts expect potential further upside if a key Singapore hospital delivers stronger-than-expected revenue after its asset enhancements, which are almost fully completed. DPU growth could also be driven by acquisitions and other asset enhancements, as the trust has ample debt headroom, the analysts say. DBS continues to like Parkway Life for its high-quality earnings visibility and maintains a buy rating and S$4.75 target price. Units rise 0.5% to S$4.09. ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"LU2237957811.SGD":"NIKKO AM GLOBAL EQUITY \"F\" (SGD) ACC","LU0384037296.USD":"ALLIANZ ASIAN MULTI INCOME PLUS \"AT\" (USD) ACC","LU0648948544.HKD":"ALLIANZ ASIAN MULTI INCOME PLUS \"AM\" (HKD) INC","IE00BKZH1Z71.USD":"BNY MELLON ASIAN INCOME \"B\" (USD) ACC","LU0865486749.SGD":"Eastspring Investments - Asian Equity Income AS SGD-H","LU1282649067.USD":"ALLIANZ ASIAN MULTI INCOME PLUS \"AMG\" (USD) INC A","8C8U.SI":"Cent Accom REIT","LU0630378429.USD":"HSBC GIF ASIA PACIFIC EX JAPAN EQ HD \"AM2\" (USD) INC","LU0441851309.USD":"JPM ASEAN EQUITY \"A\" ACC","BK6134":"医疗保健房地产信托","SG9999002604.SGD":"LionGlobal Singapore/Malaysia SGD","CFA.SI":"NikkoAM-STC Asia REIT","LU0823039010.USD":"AMUNDI FUNDS ASIA EQUITY FOCUS  \"A2\" (USD) INC","LU0345776255.USD":"NINETY ONE GSF ASIAN EQUITY \"A\" (USD) INC","LU0577902298.EUR":"FULLERTON LUX FUNDS - ASIA GROWTH & INCOME EQUITIE \"I\" (EUR) ACC","SG9999001846.SGD":"Schroder Asian Equity Yield A Dis SGD","SG9999003800.SGD":"Nikko AM Global Dividend Equity Acc SGD-H","SG9999004360.SGD":"Nikko AM Shenton Thrift Fund SGD","LU0441854154.USD":"JPM ASIA PACIFIC EQUITY \"A\" (USD) ACC","LU0955648018.USD":"SCHRODER ISF ASIAN DIVIDEND MAX \"A\" (USD) INC MF","POST":"Post Holdings","LU1211504680.USD":"ALLIANZ HIGH DIVIDEND ASIA PACIFIC EQUITY \"AM\" (USD) INC","BK6516":"银行与投资服务概念","LU0873338254.USD":"FULLERTON LUX FUNDS - ASIA GROWTH & INCOME EQUITIE \"I\" (USD) INC","LU1634259557.SGD":"Eastspring Investments - Asian Low Volatility Equity Fund AS SGD-H","IE00BGHQDM52.EUR":"GUINNESS ASIAN EQUITY INCOME \"C\" (EUR) ACC","LU0577902538.SGD":"Fullerton Lux Funds - Asia Growth and Income Equities A Acc SGD","LU0188438112.USD":"SCHRODER ISF ASIAN EQUITY YIELD \"A\" ACC","REIT":"ALPS Active REIT ETF","LU0672654166.SGD":"FTIF - Templeton Asian Growth A (acc) SGD-H1","LU0955669360.SGD":"Schroder ISF Asian Dividend Maximiser A Dis SGD","SG9999006266.SGD":"MANULIFE SINGAPORE EQUITY \"A\" (SGD) ACC","LU0823397285.USD":"BNP PARIBAS SUSTAINABLE ASIA EX-JAPAN EQUITY \"C\" (USD) INC","LU0588545904.SGD":"Eastspring Investments - Asian Equity Income ASDM SGD","SG9999002406.SGD":"利安新加坡信托基金","LU0577902371.SGD":"FULLERTON LUX FUNDS - ASIA GROWTH & INCOME EQUITIE \"I\" (SGD) ACC","PRKWF":"Parkway Life REIT","SGXZ24219693.SGD":"UNITED SG DYNAMIC INCOME FUND \"A\" (SGD) INC","LU0886674414.USD":"CT (LUX) I ASIAN EQUITY INCOME \"AUP\" (USD) INC","SG9999002620.SGD":"LionGlobal South East Asia SGD","LU1497734951.SGD":"Eastspring Investments - Asian Low Volatility Equity Fund ASDM SGD-H","LU0898667661.SGD":"JPMorgan Funds - Asia Pacific Income A (mth) SGD-H","LU0048597586.USD":"富达亚洲焦点A","SG9999013353.USD":"SCHRODER ASIAN INCOME FUND\"A\" (USDHDG) INC","BK4203":"医疗保健房地产投资信托","LU0192582467.USD":"SCHRODER ISF ASIAN EQUITY YIELD \"A\" (USD) INC MF","LU0588545490.SGD":"Eastspring Investments - Asian Equity Income AS SGD","SG9999001903.USD":"Aberdeen Standard Pacific Equity USD","C2PU.SI":"百汇生命产业信托"},"translate_title":"Parkway Life REIT今年DPU涨幅可能接近20%——市场讨论","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"PRKWF":1.5,"POST":1.5,"C2PU.SI":0.9,"CFA.SI":1.5,"8C8U.SI":1.5,"REIT":1.5},"content_text":"0316 GMT - Parkway Life REIT is likely to report a near 20% gain in distribution per unit in 2026, thanks to a projected rental step-up for Singapore hospitals, say DBS Group Research analysts in commentary. The Singapore hospital segment accounted for most of the real-estate investment trust's higher portfolio valuation, they say. The analysts expect potential further upside if a key Singapore hospital delivers stronger-than-expected revenue after its asset enhancements, which are almost fully completed. DPU growth could also be driven by acquisitions and other asset enhancements, as the trust has ample debt headroom, the analysts say. DBS continues to like Parkway Life for its high-quality earnings visibility and maintains a buy rating and S$4.75 target price. Units rise 0.5% to S$4.09. (megan.cheah@wsj.com) \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  February 02, 2026 22:16 ET (03:16 GMT)\n\n\n  Copyright (c) 2026 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"dataReport","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"}}}